1. NK-/T-cell lymphomas;Wang,2021
2. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease;Lim,2017 1
3. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type;Jo,2017
4. Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma;Kuruvilla,2017 15
5. The exportin-1 inhibitor selinexor exerts superior antitumor activity when combined with T-cell checkpoint inhibitors;Farren,2017